Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze ORMP stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ORMP investment potential.

What is ORMP stock price today?

Get real-time ORMP stock price, historical data, and price charts on Financhill. Track ORMP performance with our advanced analysis tools.

Is ORMP a good investment?

Evaluate ORMP investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ORMP stock?

To buy ORMP stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ORMP?

View detailed market capitalization data and company valuation metrics for ORMP on our comprehensive analysis page.

What is the P/E ratio of ORMP?

Use our fundamental analysis tools to view ORMP P/E ratio and compare valuation metrics with industry peers.

What are ORMP earnings?

View ORMP earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Oramed Pharmaceuticals, Inc. 10K Form

Sell

ORMP
Oramed Pharmaceuticals, Inc.

Last Price:

$3.42

Seasonality Move:

13.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09	10Q	ORMP/Oramed Pharmaceuticals, Inc. Quarterly
2023-11-09	10Q	ORMP/Oramed Pharmaceuticals, Inc. Quarterly
2023-08-10	10Q	ORMP/Oramed Pharmaceuticals, Inc. Quarterly
2023-05-11	10Q	ORMP/Oramed Pharmaceuticals, Inc. Quarterly
2022-11-10	10Q	ORMP/Oramed Pharmaceuticals, Inc. Quarterly
2022-08-10	10Q	ORMP/Oramed Pharmaceuticals, Inc. Quarterly

Receive ORMP News And Ratings

See the #1 stock for the next 7 days that we like better than ORMP

ORMP Financial Statistics

Sales & Book Value

Annual Sales:	$2M
Cash Flow:	$-626.5K
Price / Cash Flow:	0
Annual Sales:	$5.09
Price / Book:	0.69

Profitability

EPS (TTM):	1.48530
Net Income (TTM):	$63.2M
Gross Margin:	$13K
Return on Equity:	37.58%
Return on Assets:	34.51%

Oramed Pharmaceuticals, Inc. Earnings Forecast

Key Oramed Pharmaceuticals, Inc. Financial Ratios

The Gross Profit Margin over the past 22 years for ORMP is 0.65%.
The Selling, General & Administrative Expenses for ORMP have been equal to 0.00% of Gross Profit Margin.
The Research & Development expenses have been 319.05% of Revenue.
The Interest Expense is 0.00% of Operating Income.
The Net Earning history of ORMP is 3,160.40% of Total Revenues.
Per Share Earnings over the last 22 years have been positive in 9 years.

Oramed Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	ORMP
CUSIP:	68403P
Website:	oramed.com

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	6.98
Quick Ratio:	6.6

Price-to-Earnings

Trailing P/E Ratio:	2.28
Forward P/E Ratio:	0

ORMP Technical Analysis vs Fundamental Analysis